| [1] | Frappaz D., Dhall G., Murray M.J., et al. (2022). EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Neuro-Oncology 24:516−527. DOI:10.1093/neuonc/noab252 |
| [2] | Calaminus G., Frappaz D., Kortmann R.D., et al. (2017). Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial. Neuro-Oncology 19:1661−1672. DOI:10.1093/neuonc/nox122 |
| [3] | Fangusaro J., Wu S., MacDonald S., et al. (2019). Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: A Children's Oncology Group study. J. Clin. Oncol. 37:3283−3290. DOI:10.1200/JCO.19.00701 |
| [4] | Subspecialty Group of Pediatric Neurosurgery, Neurosurgical Society of Chinese Medical Association, Ma J., Chen Z.P., et al. (2026). Chinese guidelines for the diagnosis and treatment of pediatric and adolescent central nervous system nongerminomatous germ cell tumors (2026 edition). Chin. J. Neurosurg. Dis. Res. 20:8−15. DOI:10.3969/j.issn.1671-2897.2026.02.002 |
| [5] | Goldman S., Bouffet E., Fisher P.G., et al. (2015). Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: A Children's Oncology Group study. J. Clin. Oncol. 33:2464−2471. DOI:10.1200/JCO.2014.59.5132 |
| Chen Z., Cheng B.-x., Duan F.-y., et al. (2026). Management of CNS nongerminomatous germ cell tumors: Consensus recommendations bridging global trials and clinical practice. The Innovation Oncology 1:100038. https://doi.org/10.59717/j.xinn-oncol.2026.100038 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Management of CNS NGGCTs